Blockade of the mGlu5 receptor decreases basal and stress-induced cortical norepinephrine in rodents
Tóm tắt
Glutamate, the major excitatory neurotransmitter in the brain mediates its effects by both ionotropic and metabotropic receptor subtypes. Recently, the search for selective ligands for glutamate receptor subtypes has led to the discovery of 2-methyl-6-(phenylethynyl)pyridine (MPEP), an antagonist specific for metabotropic glutamate receptor 5 (mGlu5). This receptor is highly expressed in limbic forebrain regions and is thought to modulate anxiety-related processes. The noradrenergic nucleus locus coeruleus (LC) is an important mediator of stress responses and dysfunction of this system is implicated in affective disorders such as anxiety and depression. We sought to assess the effects of mGlu5 receptor antagonists, MPEP and 3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]pyridine (MTEP) on cortical norepinephrine (NE) levels. In vivo microdialysis and high-pressure liquid chromatography with electrochemical detection (HPLC-ED) were used to assess the effects of mGlu5 antagonism on extracellular NE in the frontal cortex, a major terminal field of the LC. Blockade of the mGlu5 receptor elicited significant reductions in extracellular NE in the frontal cortex. The benzodiazepine diazepam also reduced cortical NE. Furthermore, MPEP administration attenuated stress-induced increases in extracellular NE. Taken together, these data show that MPEP and MTEP, through their blockade of the mGlu5, reduce extracellular norepinephrine, the impact of which may contribute to their anxiolytic actions.
Tài liệu tham khảo
Abercrombie ED, Jacobs BL (1987) Single unit response of noradrenergic neurons in the locus coeruleus of freely moving cats. I. Acutely presented stressful and nonstressful stimuli. J Neurosci 7:2837–2843
Balazs R, Miller S, Romano C, de Vries A, Chun Y, Cotman CW (1997) Metabotropic glutamate receptor mGluR5 in astrocytes: pharmacological properties and agonist regulation. J Neurochem 69:151–163
Bremner JD, Krystal JH, Southwick SM, Charney DS (1996) Noradrenergic mechanisms in stress and anxiety. I. Preclinical studies. Synapse 23:28–38
Broderick PA (1997) Alprazolam, diazepam, yohimbine, clonidine: in vivo CA1 hippocampal norepinephrine and serotonin release profiles under chloral hydrate anesthesia. Prog Neuro-psychopharmacol Biol Psychiatry 21:1117–1140
Broderick PA, Hope O, Jeannot P (1998) Mechanism of triazolo-benzodiazepine and benzodiazepine action in anxiety and depression: behavioral studies with concomitant in vivo CA1 hippocampal norepinephrine and serotonin release detection in the behaving animal. Prog Neuro-psychopharmacol Biol Psychiatry 22:353–386
Brodkin J, Bradbury M, Busse C, Warren N, Bristow LJ, Varney MA (2002a) Reduced stress-induced hyperthermia in mGluR5 knockout mice. Eur J Neurosci 16:2241–2244
Brodkin J, Busse C, Sukoff SJ, Varney MA (2002b) Anxiolytic-like activity of the mGluR5 antagonist MPEP a comparison with diazepam and buspirone. Pharmacol Biochem Behav 73:359–366
Cosford ND, Roppe J, Tehrani L, Schweiger EJ, Seiders TJ, Chaudary A, Rao S, Varney MA (2003a) [3H]-methoxymethyl-MTEP and [3H]-methoxy-PEPy: potent and selective radioligands for the metabotropic glutamate subtype 5 (mGlu5) receptor. Bioorg Med Chem Lett 13:351–354
Cosford ND, Tehrani L, Roppe J, Schweiger E, Smith ND, Anderson J, Bristow L, Brodkin J, Jiang X, McDonald I, Rao S, Washburn M, Varney MA (2003b) 3-[(2-Methyl-1,3-thiazol-4-yl)ethynyl]-pyridine: a potent and highly selective metabotropic glutamate subtype 5 receptor antagonist with anxiolytic activity. J Med Chem 46:204–206
Cryan JF, Kelly PH, Neijt HC, Sansig G, Flor PJ, van Der Putten H (2003a) Antidepressant and anxiolytic-like effects in mice lacking the group III metabotropic glutamate receptor mGluR7. Eur J Neurosci 17:2409–2417
Cryan JF, Szeliga PJ, Gasparini F, Page ME (2003b) Potential anxiolytic-like actions of metabotropic glutamate receptor 5 (mGluR5) antagonists revealed by neurochemical and behavioral studies. Program No. 959.1. 2003 Abstract Viewer/Itinerary Planner. Society for Neuroscience, Washington, DC, Online
Dalley JW, Mason K, Stanford SC (1996) Increased levels of extracellular noradrenaline in the frontal cortex of rats exposed to naturalistic environmental stimuli: modulation by acute systemic administration of diazepam or buspirone. Psychopharmacology 127:47–54
Dazzi L, Ladu S, Spiga F, Vacca G, Rivano A, Pira L, Biggio G (2002) Chronic treatment with imipramine or mirtazapine antagonizes stress- and FG-7142-induced increase in cortical norepinephrine output in freely moving rats. Synapse 43:70–77
Duncan GE, Knapp DJ, Breese GR (1996) Neuroanatomical characterization of Fos induction in rat behavioral models of anxiety. Brain Res 713:79–91
Finlay JM, Zigmond MJ, Abercrombie ED (1995) Increased dopamine and norepinephrine release in medial prefrontal cortex induced by acute and chronic stress: effects of diazepam. Neuroscience 64:619–628
Gasparini F, Lingenhohl K, Stoehr N, Flor PJ. Heinrich M, Vranesic I, Biollaz M, Allgeier H, Heckendorn R, Urwyler S, Varney MA, Johnson EC, Hess SD, Rao SP, Sacaan AI, Santori EM, Velicelebi G, Kuhn R (1999) 2-Methyl-6-(phenylethynyl)-pyridine (MPEP), a potent, selective and systemically active mGlu5 receptor antagonist. Neuropharmacology 38:1493–1503
Heidbreder CA, Bianchi M, Lacroix LP, Faedo S, Perdona E, Remelli R, Cavanni P, Crespi F (2003) Evidence that the metabotropic glutamate receptor 5 antagonist MPEP may act as an inhibitor of the norepinephrine transporter in vitro and in vivo. Synapse 50:269–276
Ida Y, Tanaka M, Tsuda A, Tsujimaru S, Nagasaki N (1985) Attenuating effect of diazepam on stress-induced increases in noradrenaline turnover in specific brain regions of rats: antagonism by Ro 15-1788. Life Sci 37:2491–2498
Kuhn R, Pagano A, Stoehr N, Vranesic I, Flor PJ, Lingenhohl K, Spooren W, Gentsch C, Vassout A, Pilc A, Gasparini F (2002) In vitro and in vivo characterization of MPEP, an allosteric modulator of the metabotropic glutamate receptor subtype 5: review article. Amino Acids 23:207–211
LeDoux JE (2000) Emotion circuits in the brain. Annu Rev Neurosci 23:155–184
Lorrain DS, Baccei CS, Bristow LJ, Anderson JJ, Varney MA (2003) Effects of ketamine and N-methyl-d-aspartate on glutamate and dopamine release in the rat prefrontal cortex: modulation by a group II selective metabotropic glutamate receptor agonist LY379268. Neuroscience 117:697–706
Lujan, R, Roberts JDB, Shigemoto R, Ohishi H, Somogyi P (1997) Differential plasma membrane distribution of metabotropic glutamate receptors mGluR1a, mGlu2 and mGluR5, relative to neurotransmitter release. J Chem Neuroanat 13:219–241
Morilak DA, Fornal C, Jacobs BL (1987a) Effects of physiological manipulations on locus coeruleus neuronal activity in freely moving cats. I. Thermoregulatory challenge. Brain Res 422:17–23
Morilak DA, Fornal C, Jacobs BL (1987b) Effects of physiological manipulations on locus coeruleus neuronal activity in freely moving cats. II. Cardiovascular challenge. Brain Res 422:24–31
Nakane H, Shimizu N, Hori T (1994) Stress-induced norepinephrine release in the rat prefrontal cortex measured by microdialysis. Am J Physiol 267:R1559–R1566
Page ME, Lucki I (2002) Effects of acute and chronic reboxetine treatment on stress-induced monoamine efflux in the rat frontal cortex. Neuropsychopharmacology 27:237–247
Page ME, Akaoka H, Aston-Jones G, Valentino RJ (1992) Bladder distention activates noradrenergic locus coeruleus neurons by an excitatory amino acid mechanism. Neuroscience 51:555–563
Page ME, Brown K, Lucki I (2003) Simultaneous analyses of the neurochemical and behavioral effects of the norepinephrine reuptake inhibitor reboxetine in a rat model of antidepressant action. Psychopharmacology (Berl) 165:194–201
Paxinos G, Watson C (1998) The rat brain in stereotaxic coordinates. Academic Press, New York
Petty F, Jordan S, Kramer GL, Zukas PK, Wu J (1997) Benzodiazepine prevention of swim stress-induced sensitization of cortical biogenic aminess: an in vivo microdialysis study. Neurochem Res 22:1101–1104
Riedel G, Casabona G, Platt B, Macphail EM, Nicoletti F (2000) Fear conditioning-induced time- and subregion-specific increase in experession of mGlu5 receptor protein in rat hippocampus. Neuropharmacology 39:1943–1951
Rodrigues SM, Bauer EP, Farb CR, Schafe GE, LeDoux JE (2002) The group I metabotropic glutamate receptor mGluR5 is required for fear memory formation and long-term potentiation in the lateral amygdala. J Neurosci 22:5219–5229
Romano C, Sesma MA, McDonald CT, O’Malley K, Van den Pol AN, Olney JW (1995) Distribution of metabotropic glutamate receptor mGluR5 immunoreactivity in rat brain. J Comp Neurol 355:455–469
Rossetti ZL, Portas C, Pani L, Carboni S, Gessa GL (1990) Stress increases noradrenaline release in the rat frontal cortex: prevention by diazepam. Eur J Pharmacol 176:229–231
Schulz B, Fendt M, Gasparini F, Lingenhohl K, Kuhn R, Koch M (2001) The metabotropic glutamate receptor antagonist 2-methyl-6-(phenylethynyl)-pyridine (MPEP) blocks fear conditioning in rats. Neuropharmacology 41:1–7
Shigemoto R, Nomura S, Ohishi H, Sugihara H, Nakanishi S, Mizuno N (1993) Immunohistochemical localization of a metabotropic glutamate receptor, mGluR5, in the rat brain. Neurosci Lett 163:53–57
Spooren WPJ, Vassout A, Neijt HC, Kuhn R, Gasparini F, Roux S, Porsolt RD, Gentsch C (2000) Anxiolytic-like effects of the prototypical metabotropic glutamate receptor 5 antagonist 2-methyl-6-(phenylethynyl)pyridine in rodents. J Pharmacol Exp Ther 295:1267–1275
Spooren WP, Gasparini F, Salt TE, Kuhn R (2001) Novel allosteric antagonists shed light on mglu(5) receptors and CNS disorders. Trends Pharmacol Sci 22:331–337
Spooren WP, Schoeffter P, Gasparini F, Kuhn R, Gentsch C (2002) Pharmacological and endocrinological characterisation of stress-induced hyperthermia in singly housed mice using classical and candidate anxiolytics (LY314582, MPEP and NKP608). Eur J Pharmacol 435:161–170
Sullivan GM, Coplan JD, Kent JM, Gorman JM (1999) The noradrenergic system in pathological anxiety: a focus on panic with relevance to generalized anxiety and phobias. Biol Psychiatry 46:1205–1218
Swanson CJ, Schoepp DD (2003) A role for noradrenergic transmission in the actions of phencyclidine and the antipsychotic and antistress effects of mGlu2/3 receptor agonists. Ann NY Acad Sci 1003:309–317
Swanson CJ, Perry KW, Schoepp DD (2004) The mGlu2/3 receptor agonist, LY354740, blocks immobilization-induced increases in noradrenaline and dopamine release in the rat medial prefrontal cortex. Neurochemistry 88:194–202
Tanaka M, Yoshida M, Emoto H, Ishii H (2000) Noradrenaline systems in the hypothalamus, amygdala and locus coeruleus are involved in the provocation of anxiety: basic studies. Eur J Pharmacol 405:397–406
Tatarczynska E, Klodzinska A, Chojnacka-Wojcik E, Palucha A, Gasparini F, Kuhn R, Pilc A (2001) Potential anxiolytic- and antidepressant-like effects of MPEP, a potent, selective and systemically active mGlu5 receptor antagonist. Br J Pharmacol 132:1423–1430
Valentino RJ, Page ME, Curtis AL (1991) Activation of noradrenergic locus coeruleus neurons by hemodynamic stress is due to local release of corticotropin-releasing factor. Brain Res 555:25–34
Valentino RJ, Curtis AL, Page ME, Pavcovich LA, Florin S (1997) The locus coeruleus–noradrenergic system as an integrator of stress responses. In: Morrison AR, Fluharty SJ (eds) Progress in psychobiology and physiological psychology. Academic Press, San Diego
Wieronska J, Branski P, Szewczyk B, Palucha A, Papp M, Gruca P, Moryl E, Pilc A (2001) Changes in the expression of metabotropic glutamate receptor 5 (mGluR5) in the rat hippocampus in an animal model of depression. Pol J Pharmacol 53:659–662